Human immunodeficiency virus vpr product is a virion-associated regulatory protein
about
Drug-induced reactivation of apoptosis abrogates HIV-1 infectionThe Vpr protein from HIV-1: distinct roles along the viral life cycleInteraction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex.The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidationHuman immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathwayHuman immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylasesHIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomesLocalization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor proteinHuman immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repairUracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrestMaedi-visna virus and caprine arthritis encephalitis virus genomes encode a Vpr-like but no Tat proteinHuman immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzymeMutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 VprHuman immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin BThe human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycleIdentification of the 15FRFG domain in HIV-1 Gag p6 essential for Vpr packaging into the virionAnalysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiaeThe β-Lactamase Assay: Harnessing a FRET Biosensor to Analyse Viral Fusion MechanismsThe glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene productCharacterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assayInfluence of reverse transcriptase variants, drugs, and Vpr on human immunodeficiency virus type 1 mutant frequencies.Fluorescent protein-tagged Vpr dissociates from HIV-1 core after viral fusion and rapidly enters the cell nucleus.Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cellsExtracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathologyActivation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivoPrimate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction.Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayersInteraction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentivirusesHIV-1 Vpr stimulates NF-κB and AP-1 signaling by activating TAK1.Interactions with DCAF1 and DDB1 in the CRL4 E3 ubiquitin ligase are required for Vpr-mediated G2 arrest.The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cellsMaintenance of an intact human immunodeficiency virus type 1 vpr gene following mother-to-infant transmissionProduction of uninfectious human immunodeficiency virus type 1 containing viral protein R fused to a single-chain antibody against viral integrase.Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cellsVirion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins.Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopesThe interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate.Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells
P2860
Q21090718-6BF6E885-DE26-4354-BF23-7A9653DF1B68Q21245211-54190BF4-9AEC-4A5C-9DAE-FFF2D8EB75E3Q24523667-138CAA51-9608-4A54-8398-6C5E6B6E2873Q24525207-63E0AF58-5849-43C7-96DA-63306A4E06C5Q24530134-E957128E-E147-4C81-85D5-3F570C434F85Q24530147-82DF2335-67A3-4051-9325-FE8E488BCB1CQ24610197-E05B8A46-BB21-48B1-BE0F-2F991CB10E9EQ24645706-24360965-109E-435F-8318-C1B4765830F7Q24653439-6EA2D84A-84C0-4971-B48E-48DD58117215Q24673660-52ABA30B-9668-4B9A-84B7-5E3B5B6B7FC8Q24683315-E6E20C9C-E1FB-4014-8BC1-5E62EF891447Q24684302-46730DF8-517F-4C5E-8290-89A0449AAB32Q24684633-4EC14208-A9E3-4B58-ACFF-BD3E75550639Q24685157-8F413725-85B6-4449-B8E9-25C43D088406Q24685965-33E0FD53-787B-4CF7-8C3B-C5F4EA4A3267Q24797248-FC289593-C271-451E-9CC3-3009D38FE8E9Q24804945-CD3680C7-D18B-44A3-8A18-B0679FFAF622Q26747003-AADEBAE9-B62B-4C66-A369-2394B6D7073BQ28368083-A5D8F173-ABAC-4214-96C7-CDACECCF99B3Q28477791-35504F11-9661-438D-8B57-B76E1FB13C03Q30453160-52F95583-15FB-4F70-95BA-524FDEDC82B6Q30671100-B70008CE-CF44-41AD-91C8-EAAB249A470CQ30789734-DB146604-C5BC-4D3B-A9DC-4D0B77B628B9Q32068509-ED2D544C-E2A4-47C5-868E-42F0F263D93BQ33227756-2D04D53B-ACFA-4480-BEF3-6C4FA68DB2DBQ33331396-1F320696-2859-4AA9-B853-A85F5B5847A8Q33587139-CBF08661-721B-40F8-9A73-9E66606A52D4Q33601511-7751E2FA-3907-4E6F-BD39-74529C2D7F98Q33639651-66DF3BFD-C7F1-4B77-8A45-76CDACDFA957Q33756614-8F559223-F03E-477B-BCAB-6C3F500F6C0AQ33759415-5B187DEE-7CF2-4394-B89A-21D851174D64Q33782776-2FFA7515-3800-49FE-9716-9EB6761B74C5Q33783699-EBF03F31-51C3-44BE-80AE-0DAED34215E3Q33783708-88043D21-8C28-45B7-9F24-92974AAAD3D8Q33783972-27DB3A38-8788-4380-BE94-073FF2689A5EQ33784907-2E38948D-7E1B-4578-B597-3C212EE2F0ABQ33787316-22F26E9E-F9DA-46ED-86B9-1942419F3AFBQ33807693-C6304702-A3A0-4570-8721-32E609EBF65AQ33808996-E2A14686-097C-42E2-80DB-F3ABB871FDEAQ33811857-050D63E1-79A5-4913-B496-2D42EDC02DB2
P2860
Human immunodeficiency virus vpr product is a virion-associated regulatory protein
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Human immunodeficiency virus vpr product is a virion-associated regulatory protein
@ast
Human immunodeficiency virus vpr product is a virion-associated regulatory protein
@en
Human immunodeficiency virus vpr product is a virion-associated regulatory protein
@nl
type
label
Human immunodeficiency virus vpr product is a virion-associated regulatory protein
@ast
Human immunodeficiency virus vpr product is a virion-associated regulatory protein
@en
Human immunodeficiency virus vpr product is a virion-associated regulatory protein
@nl
prefLabel
Human immunodeficiency virus vpr product is a virion-associated regulatory protein
@ast
Human immunodeficiency virus vpr product is a virion-associated regulatory protein
@en
Human immunodeficiency virus vpr product is a virion-associated regulatory protein
@nl
P2093
P2860
P3181
P1433
P1476
Human immunodeficiency virus vpr product is a virion-associated regulatory protein
@en
P2093
P2860
P304
P3181
P407
P577
1990-06-01T00:00:00Z